Search details
1.
The Association Between Self-Reported Anxiety and Retention in Opioid Agonist Therapy: Findings From a Canadian Pragmatic Trial.
Can J Psychiatry
; 69(3): 172-182, 2024 03.
Article
in English
| MEDLINE | ID: mdl-37697811
2.
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes.
Can J Psychiatry
; : 7067437241245384, 2024 May 06.
Article
in English
| MEDLINE | ID: mdl-38711351
3.
Impact of Depressive Symptom Severity on Buprenorphine/Naloxone and Methadone Outcomes in People With Prescription-Type Opioid Use Disorder: Results From a Pragmatic Randomized Controlled Trial.
J Dual Diagn
; : 1-12, 2024 Apr 05.
Article
in English
| MEDLINE | ID: mdl-38580298
4.
Factors Associated with Bothersome Symptoms in Individuals With and Without HIV Who Report Alcohol Use.
AIDS Behav
; 27(7): 2455-2462, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-36622487
5.
Comparative Efficacy and Tolerability of Antipsychotics for Juvenile Psychotic Disorders: A Systematic Review and Network Meta-Analysis.
J Clin Psychopharmacol
; 42(2): 198-208, 2022.
Article
in English
| MEDLINE | ID: mdl-35020712
6.
Making a case for the inclusion of refractory and severe mental illness as a sole criterion for Canadians requesting medical assistance in dying (MAiD): a review.
J Med Ethics
; 48(11): 929-934, 2022 11.
Article
in English
| MEDLINE | ID: mdl-33849958
7.
Prevalence and factors associated with polypharmacy: a systematic review and Meta-analysis.
BMC Geriatr
; 22(1): 601, 2022 07 19.
Article
in English
| MEDLINE | ID: mdl-35854209
8.
Ketamine for Bipolar Depression: A Systematic Review.
Int J Neuropsychopharmacol
; 24(7): 535-541, 2021 07 23.
Article
in English
| MEDLINE | ID: mdl-33929489
9.
Comparative Efficacy and Tolerability of Adjunctive Pharmacotherapies for Acute Bipolar Depression: A Systematic Review and Network Meta-analysis.
Can J Psychiatry
; 66(3): 274-288, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33174452
10.
Psychotherapies for Adolescents with Subclinical and Borderline Personality Disorder: A Systematic Review and Meta-Analysis.
Can J Psychiatry
; 65(1): 5-15, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31558033
11.
Cannabinoids for the Neuropsychiatric Symptoms of Dementia: A Systematic Review and Meta-Analysis.
Can J Psychiatry
; 65(6): 365-376, 2020 06.
Article
in English
| MEDLINE | ID: mdl-31835954
12.
Concerns regarding the recommendation against prescribing selective serotonin reuptake inhibitors in the Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder.
CMAJ
; 196(10): E346-E347, 2024 Mar 17.
Article
in English
| MEDLINE | ID: mdl-38499302
13.
Préoccupations en ce qui concerne la recommandation contre la prescription d'inhibiteurs sélectifs de la recapture de la sérotonine dans la Ligne directrice canadienne pour la prise en charge clinique de la consommation d'alcool à risque élevé et du trouble d'utilisation de l'alcool.
CMAJ
; 196(19): E685-E686, 2024 May 20.
Article
in French
| MEDLINE | ID: mdl-38772607
14.
Characterizing inpatient care for adults with schizophrenia using the Health Quality Ontario indices: A single-centre retrospective cohort study.
Clin Invest Med
; 41(4): E196-E203, 2019 01 30.
Article
in English
| MEDLINE | ID: mdl-30737979
15.
Training in Substance use Disorders, Part 1: Overview of Clinical Practice Recommendations.
Can J Psychiatry
; 69(6): 428-456, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38613369
16.
Training in Substance Use Disorders, Part 2: Updated Curriculum Guidelines.
Can J Psychiatry
; 69(6): 457-478, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38533564
17.
Endocarditis in the setting of IDU: multidisciplinary management.
Curr Opin Cardiol
; 33(2): 140-147, 2018 03.
Article
in English
| MEDLINE | ID: mdl-29232248
18.
Evidence base to support using prescribed psychostimulants to treat psychostimulant use disorder is limited.
CMAJ
; 195(39): E1354, 2023 10 10.
Article
in English
| MEDLINE | ID: mdl-37816523
19.
The Rising Tide of Stimulant-Related Morbidity and Mortality Warrants Evidence-Based Treatment.
Can J Psychiatry
; 68(3): 208-209, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36113454
20.
Listening to the Patient's Voice: A Patient-Centred Approach to Treatment-Resistant Schizophrenia.
Can J Psychiatry
; 67(3): 235-237, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34889122